Dr. Marc Stuart Zumberg, MD

Dr. Zumberg practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Zumberg's NPI, 1487691895, was assigned on June 2, 2006. Dr. Zumberg graduated from University Of Michigan Medical School in 1994. Dr. Zumberg holds Florida license ME69422.

Dr. Zumberg's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Zumberg's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zumberg practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zumberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zumberg is board certified in hematology by the American Board of Internal Medicine. Dr. Zumberg is licensed in Florida.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Zumberg treats.

CMS data shows 982 Medicare services from Dr. Zumberg across 11 procedure codes in 2024, for 459 Medicare patients. Medicare paid $60,612 for them.

CMS counts 459 Medicare patients who saw Dr. Zumberg in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zumberg's median patient age at 71, with 59% women.

In 2024, Dr. Zumberg wrote 416 Medicare Part D claims for 80 patients. 80% of them were for generic drugs. CMS names the drug for 335 of them, across 7 drugs with 11 or more claims each, at $64,668 in total drug cost. In 2023, CMS named 346 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Zumberg for performance year 2024, reported through an alternative payment model (APM). Dr. Zumberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zumberg as offering telehealth.

Dmand AI links 51 papers to Dr. Zumberg, published from 2007 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Anticoagulants, Anemia, Sickle Cell and Hemorrhage. Dr. Zumberg has published most often in Blood Coagul Fibrinolysis. Dr. Zumberg's most frequent co-authors are Neil Selwyn Harris, MD, Ali Ataya, MD and Jeb Mahan Justice, MD.

Dmand AI links Dr. Zumberg to 1 clinical trial. Conditions studied include Antiphospholipid Syndrome and Autoimmune Diseases.

CMS Open Payments shows 13 general payments to Dr. Zumberg from 6 drug and device companies from 2020 to 2024. Consulting fees make up the largest share, 93% of the total. Sanofi and Genzyme US Companies paid the most, $12,604.

Dmand AI lists 1 award for Dr. Zumberg, most recently CMS Stage 1 EHR in 2013.

Dr. Zumberg graduated from University Of Michigan Medical School in 1994.

Dr. Zumberg is in network with 17 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.